Skip to main content
Công ty Cổ phần Dược phẩm Cửu Long logo

Công ty Cổ phần Dược phẩm Cửu Long — Investor Relations & Filings

Ticker · DCL ISIN · VN000000DCL1 HSX Manufacturing
Open in API
Filings indexed 224 across all filing types
Latest filing 2025-12-15 Regulatory Filings
Country VN Viet Nam
Listing HSX DCL

About Công ty Cổ phần Dược phẩm Cửu Long

http://dcl.com.vn

Cuu Long Pharmaceutical Joint Stock Company (DCL) is a diversified healthcare provider with nearly 50 years of operational history. The company's core activities include the production of pharmaceuticals, medical equipment, and empty hard capsules. DCL is a market leader in empty hard capsules, holding approximately 80% market share. Its pharmaceutical portfolio comprises a range of drugs, chemicals, and medicines. The company serves a broad network of hospitals and medical facilities through an extensive distribution system. DCL is recognized for its commitment to delivering innovative and accessible healthcare products.

Recent filings

Filing Released Lang Actions
DCL: Thông báo về việc chấm dứt hoạt động chi nhánh tại Sóc Trăng
Regulatory Filings Classification · 89% confidence The document is a mandatory “Extraordinary Information Disclosure in 24 Hours” filed by a Vietnamese public company with the State Securities Commission and Ho Chi Minh Stock Exchange. It announces the termination of a branch but contains no financial statements, no detailed report, and is simply a regulatory update. This falls under general regulatory announcements that do not fit other categories.
2025-12-15 Vietnamese
DCL: Thông báo thay đổi nhân sự - Bổ nhiệm Phó Tổng Giám đốc
Board/Management Information Classification · 85% confidence The document is a formal notification and board resolution concerning the appointment of a new Deputy General Director. It is clearly an announcement of senior management changes, matching the definition for Board/Management Information (MANG).
2025-12-01 Vietnamese
DCL: Giải trình biến động LNST quý 3/2025 so với cùng kỳ năm trước
Management Reports Classification · 82% confidence The document is an explanatory submission to the Vietnamese securities regulator and stock exchange that details reasons for the change in profit after tax between Q3 2025 and Q3 2024. It is not the full quarterly report (no full financial statements), nor a brief publication notice. Instead, it provides a management’s detailed explanation of financial result variations, fitting the Management Reports (MDA) category.
2025-10-29 Vietnamese
DCL: Giấy chứng nhận đăng ký doanh nghiệp thay đổi lần thứ 28
Regulatory Filings Classification · 85% confidence The document is an announcement to the Ho Chi Minh Stock Exchange regarding the change in the company’s Certificate of Business Registration, detailing pre‐ and post‐change information, effective date, and attached certificate. It is a regulatory disclosure of administrative data changes rather than a financial report, earnings release, management discussion, or capital transaction. It does not constitute a full report itself but serves as a general regulatory announcement. Therefore, it falls under the catch‐all Regulatory Filings category.
2025-09-18 Vietnamese
DCL: Giải trình biến động LNST bán niên năm 2025 so với cùng kỳ năm trước
Regulatory Filings Classification · 85% confidence The document is a standalone regulatory disclosure letter (“Giải trình biến động lợi nhuận sau thuế bán niên”) sent to the State Securities Commission and the Ho Chi Minh Stock Exchange under Circular 96/2020 to explain half‐year profit fluctuations. It is not a full interim report (no complete financial statements), not an earnings release (it includes detailed tables and explanations), nor a notice of report publication. It is a compliance filing with numeric analyses, so it falls into the fallback category “Regulatory Filings (RNS).”
2025-08-28 Vietnamese
DCL: Giải trình biến động LNST trên BCTC quý 2/2025 so với cùng kỳ năm trước
Regulatory Filings Classification · 85% confidence The document is an official submission to the State Securities Commission and Ho Chi Minh Stock Exchange under Circular 96/2020/TT-BTC, providing a detailed "giải trình" (explanation) of the change in net profit after tax for Q2 2025 versus Q2 2024. It does not include full financial statements (so it is not an interim/quarterly report) nor is it a press-style earnings release aiming at investors. It is a mandated regulatory disclosure of explanations of financial variances. Therefore, it fits the "Regulatory Filings" category.
2025-07-30 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.